{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/allergic-rhinitis/background-information/complications/","result":{"pageContext":{"chapter":{"id":"ab993d04-4c7b-59cd-9e56-2e0ef7fdc9db","slug":"complications","fullItemName":"Complications","depth":2,"htmlHeader":"<!-- begin field 613ac16d-21c8-4e9a-99f0-19174fc742bc --><h2>What are the complications?</h2><!-- end field 613ac16d-21c8-4e9a-99f0-19174fc742bc -->","summary":"","htmlStringContent":"<!-- begin item 435929b2-b9e8-4771-9100-98ef6c4548ac --><!-- begin field 93c2cb66-2e69-474c-9233-a91a00e768c9 --><p><strong>Complications of allergic rhinitis include:</strong></p><ul><li>Impaired quality of life — allergic rhinitis can adversely affect work, home, and social life, especially during the peak pollen season [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Roberts, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Brozek, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Lipworth, 2017</a>].</li><li>Impaired school performance — poorly controlled symptoms in children may cause difficulty concentrating, irritability, and sleep disturbance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Roberts, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Brozek, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Lipworth, 2017</a>].</li><li>Asthma — allergic rhinitis and asthma often co-exist, and allergic rhinitis is a risk factor for the development of asthma [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Roberts, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Barr, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Brozek, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Lipworth, 2017</a>]. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/asthma/\">Asthma</a> for more information.<ul><li>An Australian longitudinal cohort study of children (n = 7383) found that allergic rhinitis in childhood was associated with a seven-fold increased risk of asthma in the pre-adolescent period, and a three-fold increased risk of asthma persisting into adulthood [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Burgess, 2007</a>]. The 2016 revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) international guideline notes that asthma is found in 15–38% of people with allergic rhinitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Brozek, 2017</a>].</li><li>Co-morbid allergic and non-allergic rhinitis affect over 80% of people with asthma. People with asthma with severe rhinitis symptoms are four times more likely to have poorly controlled asthma than those without [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Scadding, 2012</a>].</li></ul></li><li>Sinusitis and nasal polyps — sinusitis is a common complication of allergic rhinitis. It is thought that swelling of the nasal mucosa leads to obstruction of the drainage of the sinuses, predisposing to the development of sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Lipworth, 2017</a>]. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/sinusitis/\">Sinusitis</a> for more information.</li><li>Oral allergy syndrome (pollen-food syndrome) — allergic rhinitis can be associated with oral allergy syndrome, where symptoms of oral itching and swelling occur due to cross-reactivity between aeroallergens, such as birch pollen, and vegetables and fruits such as apples [<a class=\"bibliography-reference internal-reference\" href=\"/topics/allergic-rhinitis/references/\">Roberts, 2013</a>].</li></ul><!-- end field 93c2cb66-2e69-474c-9233-a91a00e768c9 --><!-- end item 435929b2-b9e8-4771-9100-98ef6c4548ac -->","topic":{"id":"e84371ef-9d30-56df-8358-1520fb2c324f","topicId":"0473d89c-2999-40d1-911f-d265b4bd3942","topicName":"Allergic rhinitis","slug":"allergic-rhinitis","lastRevised":"Last revised in September 2018","chapters":[{"id":"5fa28a05-233b-5de6-aee8-ea0327f3c7d6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ea1f0c07-a5f8-599b-9b96-71ef8590b2a6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"99b142c6-9593-51c7-9c86-7c8a537a3b8c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"67cd9666-b198-574f-9fbf-cd740a7d8c3e","slug":"changes","fullItemName":"Changes"},{"id":"7d544db5-f3b7-5709-a2ae-076455d76d20","slug":"update","fullItemName":"Update"}]},{"id":"392391e3-b09a-5cab-ae2a-040eb039abd9","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"292568d8-a1f5-5b8f-a13d-f3c014fa8e95","slug":"goals","fullItemName":"Goals"},{"id":"2f7129b7-e08b-5e5f-997c-4b661ce0a778","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8062582a-18e3-58d5-a8cb-f9689e259444","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1e562233-ae40-5755-abc7-71551f4cea02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ccab909c-169d-52aa-ac0a-9d425f89a99c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"37d61d5d-e2f1-58ef-9c6a-27c4011784f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84432cb8-00ce-599e-9e05-3493755dacd6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f59296af-8e0a-509d-b8f3-692efd2bdb92","slug":"definition","fullItemName":"Definition"},{"id":"37020833-afb2-529a-975a-1f1a7a5db2ef","slug":"causes","fullItemName":"Causes"},{"id":"962f75f0-d73d-5c7c-aaf4-d08fc672e6be","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ab993d04-4c7b-59cd-9e56-2e0ef7fdc9db","slug":"complications","fullItemName":"Complications"},{"id":"68b348fd-2864-5da4-8687-6d8c25004f1b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"80c9e7d3-3315-55b9-98fb-2261b95a1b5c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"3cc3ef09-2238-5504-8781-48914ad6a4c9","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"5a3f0e38-3f88-5049-beaa-f4cb26499dc6","slug":"assessment","fullItemName":"Assessment"},{"id":"5bd413c7-0398-5b71-acad-a5699c7c703b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9b8b1dfa-dfda-5292-a329-64d2c435a006","fullItemName":"Management","slug":"management","subChapters":[{"id":"a132cc60-bb1b-5679-8eda-db080a1e772a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"760f3c4d-0984-5865-acbe-65d470f66518","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a47a2aa5-0821-5bf5-987b-2397ac2c982f","slug":"intranasal-antihistamines","fullItemName":"Intranasal antihistamines"},{"id":"449809a3-a714-573e-a21f-8e4295eb984e","slug":"oral-antihistamines","fullItemName":"Oral antihistamines"},{"id":"5507fb81-aa18-5a21-b619-8db3c3c78e80","slug":"intranasal-cromones","fullItemName":"Intranasal cromones"},{"id":"5102b868-dccf-58c1-b6c7-3a59a24c6602","slug":"intranasal-decongestants","fullItemName":"Intranasal decongestants"},{"id":"623ba003-b473-5be2-bc25-e438f1500f7c","slug":"intranasal-anticholinergics","fullItemName":"Intranasal anticholinergics"},{"id":"c871daa0-d649-59f1-b13c-79ab64e7083e","slug":"oral-leukotriene-receptor-antagonists","fullItemName":"Oral leukotriene receptor antagonists"}]},{"id":"f3877d58-da5a-5655-8752-49e87f3a410b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"87371e7f-8741-54ef-9af6-339f8f0b9285","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"318f5be9-46cf-5fb9-b28c-7ebb4a901904","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49c3da95-9d4f-5a93-a7ca-e71965fcb981","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"33a2085c-95d6-5004-8f1f-50a08684c638","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4b1a0d4a-fd5e-5b81-9293-5b2f004871cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"735b627c-7d7e-58b8-8196-b4972220342b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"92889a85-b6e7-58f3-9f09-eae6ca76386c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"84432cb8-00ce-599e-9e05-3493755dacd6","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}